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In eubacteria, green algae, and plant chloroplasts, isopentenyl diphosphate, a key intermediate in the biosyn-
thesis of isoprenoids, is synthesized by the methylerythritol phosphate pathway. The five carbons of the basic
isoprenoid unit are assembled by joining pyruvate and D-glyceraldehyde 3-phosphate. The reaction is catalyzed
by the thiamine diphosphate-dependent enzyme 1-deoxy-D-xylulose 5-phosphate synthase. In Rhodobacter cap-
sulatus, two open reading frames (ORFs) carry the genes that encode 1-deoxy-D-xylulose 5-phosphate synthase.
ORF 2816 is located in the photosynthesis-related gene cluster, along with most of the genes required for
synthesis of the photosynthetic machinery of the bacterium, whereas ORF 2895 is located elsewhere in the ge-
nome. The proteins encoded by ORF 2816 and ORF 2895, 1-deoxy-D-xylulose 5-phosphate synthase A and B,
containing a His6 tag, were synthesized in Escherichia coli and purified to greater than 95% homogeneity in two
steps. 1-Deoxy-D-xylulose 5-phosphate synthase A appears to be a homodimer with 68 kDa subunits. A new as-
say was developed, and the following steady-state kinetic constants were determined for 1-deoxy-D-xylulose
5-phosphate synthase A and B: Km
pyruvate 5 0.61 and 3.0 mM, Km
D-glyceraldehyde 3-phosphate 5 150 and 120 mM,
and Vmax 5 1.9 and 1.4 mmol/min/mg in 200 mM sodium citrate (pH 7.4). The ORF encoding 1-deoxy-D-
xylulose 5-phosphate synthase B complemented the disrupted essential dxs gene in E. coli strain FH11.
Isoprenoid compounds form a large, ubiquitous class of nat-
ural products consisting of over 30,000 individual members.
They have a wide variety of cellular functions—such as com-
ponents of cell membranes (sterols), electron transport (ubi-
quinones), signal transduction (prenylated proteins), photo-
synthetic pigments (chlorophylls), and cell wall biosynthesis
(dolichols)—essential for viability (39). Until recently, all iso-
prenoid compounds were thought to be synthesized from
acetyl coenzyme A by the widely accepted mevalonate (MVA)
pathway found in eukaryotes and archaebacteria (33). Work
stimulated by finding labeling patterns in bacterial hopanoids
and ubiquinones inconsistent with their biosynthesis by the
MVA pathway (32, 37) led to the discovery of a new, indepen-
dent route to these molecules in many bacteria, green algae,
and plants (for reviews, see references 10 and 36). In the newly
discovered pathway, the five carbon atoms in the basic isopre-
noid unit are derived from pyruvate and D-glyceraldehyde
3-phosphate (GAP). As shown in Fig. 1, pyruvate and GAP are
condensed to give 1-deoxy-D-xylulose 5-phosphate (DXP). In
addition to serving as a precursor for the biosynthesis of thia-
mine and pyridoxol, DXP undergoes rearrangement and re-
duction to form 2-methylerythritol 4-phosphate (MEP), the
first committed intermediate in the MEP pathway for biosyn-
thesis of isoprenoids (19, 47). MEP is then appended to CMP
to form a cytidine derivative (35), and this is followed by
phosphorylation of the C-2 hydroxyl group (28) and elimina-
tion of CMP to form a 2,4-cyclic diphosphate (16). The re-
maining steps to the fundamental five-carbon isoprenoid build-
ing blocks, isopentenyl diphosphate (IPP) and dimethylallyl
diphosphate (DMAPP), have not been established. For most
organisms reported to date, the enzymes in the MEP pathway
are encoded by essential single-copy genes. The exception is a
strain of Streptomyces, which contains both the MEP and MVA
pathways (44).
DXP synthase (DXPase) lies just before the branch point to
the B vitamins and isoprenoids. Genes encoding the enzyme
have been cloned from Escherichia coli (27, 46), Streptomyces
sp. strain CL190 (18), Mentha 3 piperita (21), and Capsicum an-
nuum (5). Disruption of the E. coli dxs gene is lethal. DXPase
catalyzes the decarboxylation of pyruvate and the subsequent
condensation of the thiamine-bound two-carbon intermediate
with GAP in a reaction similar to those catalyzed by transke-
tolases. Interestingly, DXPases contain regions with strong ho-
mology to the E1 subunit of pyruvate dehydrogenases and to
transketolases (46). Although recombinant forms of the en-
zyme can use either GAP or D-glyceraldehyde as cosubstrates
with pyruvate, the phosphorylated form of the deoxy-sugar
appears to be the normal intermediate in the pathway (47).
Rhodobacter capsulatus is a purple nonsulfur bacterium that
can grow by respiration in an aerobic environment or utilize its
photosynthesis machinery to grow anaerobically. The genes for
photosynthesis are located in a 46-kb cluster that encodes all of
the enzymes needed to synthesize the carotenoids and the C20
isoprenoid chain in bacteriochlorophyll from IPP. Although
most of the genes are present as single copies in the bacterial
genome, the probable existence of two copies of idi, the gene
for IPP isomerase, one located in the photosynthesis cluster
and one located elsewhere on the chromosome, has been pre-
viously reported (13). We now report that R. capsulatus has
two DXPase genes as well. One, dxsA (open reading frame
[ORF] 2816) is located in the photosynthesis cluster, and the
other, dxsB (ORF 2895), is located elsewhere in the chromo-
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some. Plasmid-located R. capsulatus dxsB can complement
E. coli FH11, in which the chromosomal copy of dxs is dis-
rupted. FH11 can also be complemented by growth on 2-meth-
ylerythritol (ME) or MVA when transformed with a plasmid
containing an “operon” consisting of the three yeast genes
required for biosynthesis of IPP from MVA. The recombinant
R. capsulatus DXPases encoded by dxsA and dxsB were puri-
fied, and the steady-state kinetic studies were conducted using a
new assay.
MATERIALS AND METHODS
Materials. Sodium [2-14C]pyruvate was purchased from Dupont/NEN. Triose-
phosphate isomerase (TIM), D-glyceraldehyde, dihydroxyacetone phosphate
(DHAP), pyruvic acid, isopropyl-b-D-thiogalactoside (IPTG), leupeptin, GAP,
and pepstatin were purchased from Sigma. Thiamine diphosphate (TPP) was
purchased from ICN Biomedicals, Inc. Imidazole was purchased from Acros
Organics. Ni-nitrilotriacetate silica resin was purchased from Qiagen. All restric-
tion endonucleases, Klenow, and T7 DNA polymerase were purchased from New
England Biolabs. Deoxynucleoside triphosphates and T4 DNA ligase were pur-
chased from Pharmacia. Shrimp alkaline phosphatase (SAP) and dithiothreitol
were purchased from U.S. Biochemical Corp. Plasmid pFL226 was provided by
J. E. Hearst (Lawrence Berkeley Laboratories, Berkeley, Calif.). Phage DD92
was provided by F. R. Blattner (University of Wisconsin, Madison, Wis.). Plas-
mid pMAK705 was provided by S. R. Kushner (University of Georgia, Athens,
Ga.). Plasmid pNGH1-amp was provided by C. R. H. Raetz (Duke University,
Durham, N.C.). Oligonucleotide primers and linkers were synthesized by the
Protein/DNA Core Facility of the Utah Regional Cancer Center. ME was syn-
thesized by the procedure of Duvold et al. (8). DXP and 1-deoxy-D-xylulose
(DXS) were synthesized by the procedure of Blagg and Poulter (3).
Bacterial strains and growth conditions. The strains used in this study are
listed in Table 1 and were grown at 30, 37, or 44°C in Luria-Bertani (LB) medium
supplemented with the following antibiotics as necessary: ampicillin (50 mg/ml),
chloramphenicol (30 mg/ml), or kanamycin (25 mg/ml).
General methods. Minipreparations of plasmid DNA for restriction analysis
were obtained by the boiling method as described by Sambrook et al. (40).
Large-scale plasmid preparations (.100 mg) were made using the Qiagen plas-
mid Midi kit. DNA fragments were purified on agarose gels (Bio-Rad) using a
Geneclean II kit from Bio 101. Restriction digestions, ligations, and transforma-
tions of competent E. coli cells were conducted as described by Sambrook et al.
(40). Site-directed mutagenesis was performed by the procedure of Kunkel (17)
using the Muta-Gene Phagemid in vitro mutagenesis kit (version 2; Bio-Rad).
PCR was performed using a Perkin-Elmer GeneAmp PCR System 2400 DNA
thermal cycler and the polymerase mix provided in the Advantage PCR Kit
(Clontech). DXPase was assayed by the procedure reported below. Radioactivity
was measured in Ultima Gold scintillation fluid (Packard) using a Packard
Tri-Carb 2300TR liquid scintillation analyzer. Size exclusion and affinity chro-
matography was conducted at 4°C using a Pharmacia fast protein liquid chro-
FIG. 1. MEP pathway for isoprenoid biosynthesis.
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matography system. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed using the discontinuous buffer system of Laemmli
(20), and the gels were stained with Coomassie brilliant blue R (Sigma). Protein
concentrations were determined by the method of Bradford (6) using bovine
serum albumin (BSA) as a standard.
Sequence analysis. Sequence searches were performed at the National Center
for Biotechnology Information (NCBI). Pairwise sequence alignments were per-
formed at the ExPASy Proteomics Tools website using the SIM program or with
Vector NTI. Multiple-sequence alignments were performed using Vector NTI
and the ClustalW 1.7 and PIMA 1.4 alignment methods at the Baylor College of
Medicine Search Launcher website. DNA was sequenced at the Health Sciences
Center Sequencing Facility, Eccles Institute of Human Genetics, University of
Utah.
Plasmid constructions. The plasmids used in this study are listed in Table 1.
Plasmid pFL226 is a derivative of pBR325 and contains a 9.8-kb BamHI frag-
ment of the R. capsulatus photosynthesis gene cluster. pFL226 was restricted with
SalI and BamHI, and the purified 2.5-kb fragment was ligated into pBluescript
SK(1) to yield pDX1. Site-directed mutagenesis was employed to introduce a
unique NdeI site at the start of ORF 2816 using primer 59-GCTCATCGGAGG
ACGCACATATGAGCGCCACGCCATCCC-39 to yield pDX2. The new NdeI
site is underlined, and the start codon of ORF 2816 is in bold. The purified 2.0-kb
fragment was subcloned into the NdeI and BamHI sites of E. coli expression
vector pET11a to give pFMH28. The newly introduced ORF was sequenced and
was identical to the deposited sequence for ORF 2816 (GenBank accession no.
Z11165).
Plasmid pDX2 was modified to introduce a glycine and six histidine residues
at the C terminus of the protein using site-directed mutagenesis and primer
59-CGGTGCGGATCGTGCACAGCGCGGGG(CAT)6TAACTCGAGGCGAC
ACTGCAAAGATGCACGG-39 to yield pDX3. A unique XhoI site introduced
for screening is underlined, the codons for the new Gly and His residues are in
bold, and the stop codon for the ORF is in italics. pDX3 was restricted with NdeI
and BamHI, and the 2.0-kb fragment was ligated into pET11a to yield pFMH30.
ORF 2895 was isolated from R. capsulatus genomic DNA by PCR using the
primers (sense) 59-CGGAATTCATGAGCCAGCCCCCAGTGACCCCGATC
CTCGACCGCGTGCGTCTG-39 and (antisense) 59-CGGGATCCTCAGGC
GCGTTTCGCCACCGCGACGCCGAGCAGATCGAGCACTTTCG-39. The
;2-kb PCR product was restricted with EcoRI-BamHI and subcloned into the
pACYC177 derivative pNGH1-amp to give pFMH39. The ORF contained
within pFMH39 was sequenced and was identical to the sequence deposited at
the Rhodobacter Capsulapedia website (see above).
The ORF encoding DXPase-B was then modified to introduce six histidine
residues at the C terminus of the protein by PCR using the primers (sense)
59-GAGATATACATATGAGCCAGCCCCCAGTG-39 and (antisense) 59-TCT
AGGATCCTCA(ATG)6GGCGCGTTTCGCCTC-39. Unique NdeI (sense) and
BamHI (antisense) sites are underlined, the codons for the new His residues are
in bold, and the stop codon is in italics. The ;2-kb PCR product was restricted
with NdeI-BamHI, purified, and subcloned into E. coli expression vector pET11a
to give pLME10.
Within phagemid DD92 is a 19.8-kb EcoRI fragment of E. coli genomic DNA
containing dxs, the gene for DXPase (Table 1). Following the isolation of the
phage from E. coli strain LE392, DD92 was restricted with SphI and SmaI to give
a 2.0-kb fragment containing E. coli dxs. The purified DNA fragment was ligated
into the SphI and HindII sites of pMAK705, a plasmid containing a temperature-
sensitive origin of replication (14). The resulting plasmid, pDX4, was restricted
with SapI at a unique site located in the middle of the dxs gene, and the 59
overhangs were filled in with the Klenow fragment and treated with SAP as
specified by the manufacturer. A 1.3-kb blunt-ended DNA fragment containing
the gene for Kanr from pUC4K (51) (Amersham Pharmacia Biotech catalog,
1999) was then ligated into the linearized pDX4 DNA to create pDX5 with a
disruption in E. coli dxs.
Plasmids pFCO1 and pFCO2 containing a synthetic operon for the in vivo
synthesis of IPP from mevalonate were constructed as follows: ERG12, ERG8,
and ERG19 were isolated from S. cerevisiae genomic DNA by PCR using the
respective primer sets FH0129-2 (sense) 59-GGACTAGTCTGCAGGAGGAG
TTTTAATGTCATTACCGTTCTTAACTTCTGCACCGGG-39 and FH0129-1
(antisense) 59-TTCTCGAGCTTAAGAGTAGCAATATTTACCGGAGCAGTTACA
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Descriptiona Source
E. coli
DH5l Host for cloning vectors Life Technologies
CJ236 Host for mutagenesis experiments Bio-Rad
BL21-DE3 Host for protein synthesis Novagen
LE392 Host for phage DD92 propagation Stratagene
JM101 Host for disruption experiments Stratagene
FH11 JM101 dxs::Kanr/pDX4 This work
Plasmids and phages
pFL226 pBR325 with the 9.7-kb BamHI fragment corresponding to bp 36280–45954 of the 46-kb photosynthesis
gene cluster (EMBL accession no. Z11165)
J. E. Hearst
DD92 Double-stranded l-phagemid with a 19.8-kb EcoRI fragment of E. coli genomic DNA containing
the dxs gene
F. R. Blattner
pMAK705 Camr, temperature-sensitive origin of replication S. R. Kushner
pNGH1-Amp pACYC177 derivative for complementation studies C. R. H. Raetz
pUC4K Contains Kanr cassette Pharmacia
pBS(SK1) pBluescript cloning vector; Ampr Stratagene
pET11a E. coli expression vector; Ampr; T7 promoter Novagen
pGEM-T Easy Cloning vector for PCR products; Ampr
pDX1 pBS(SK1) with the 2.5-kb BamHI-SalI fragment of pFL226 This work
pDX2 pDX1 with an NdeI site introduced by Kunkel mutagenesis This work
pFMH28 pET11a with the 2.0-kb NdeI-BamHI fragment of pDX2 containing ORF 2816 This work
pDX3 pDX3 with ORF 2816 modified by Kunkel mutagenesis to add 6 His residues to the C terminus of
R. capsulatus DXPase-A
This work
pFMH30 pET11a with the 2.0-kb NdeI-BamHI fragment of pDX3 This work
pDX4 pMAK705 with the 2.0-kb SphI-SmaI fragment of DD92 containing E. coli dxs This work
pDX5 pMAKDXS with the 1.3-kb EcoRI Kanr cassette from pUC4K inserted into E. coli dxs This work
pFMH39 pNGH1-Amp with the 1.9-kb EcoRI-BamHI fragment containing ORF 2895 This work
pBRG12 pBS(SK1) with the PCR product containing ERG12 adjacent to 54 bp of the 59 end of ERG19 This work
pERG8 pGEM-T Easy with the PCR product containing ERG8 This work
pERG19 pGEM-T Easy with the PCR product containing ERG19 This work
pBRG812 pBRG12 with the 1.4-kb NotI-PstI fragment of pERG8 containing ERG8 This work
pFCO1 pBRG812 with the 1.1-kb AflII-XhoI fragment of pERG12 containing the rest of ERG19 This work
pFCO2 pNGH1-Amp with the 4.1-kb SacI-XhoI fragment of pFCO1 containing ERG8, ERG12, and ERG19 This work
pLME10 pET11a with the 2.0-kb NdeI-BamHI fragment containing ORF 2895-6 His This work
a Camr, chloramphenicol resistance; Kanr, kanamycin resistance; Ampr, ampicillin resistance.
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CTAGCAGTATATACAGTCATTAAAACTCCTCCTGTGAAGTCCATGGTAA
ATTCG-39, FH0211-2 (sense) 59-TAGCGGCCGCAGGAGGAGTTCATATG
TCAGAGTTGAGAGCCTTCAGTGCCCCAGGG-39 and FH0211-1 (antisense)
59-TTTCTGCAGTTTATCAAGATAAGTTTCCGGATCTTT-39, and CT0419
(sense) 59-GGAATTCATGACCGTTTACACAGCATCCGTTACCGCACCC
G-39 and CT0419-2 (antisense) 59-GGCTCGAGTTAAAACTCCTCTTCCTTT
GGTAGACCAGTCTTTGCG-39. Primer FH0129-2 included a SpeI site (un-
derlined). Primer FH0129-1 contained a XhoI site (underlined), an AflII site
(double underlined), and 54 nucleotides corresponding to the 59 end of ERG19
(bold italics). Following restriction with SpeI-XhoI, the PCR product containing
ERG12 was subcloned into pBluescript SK(1) to create pBRG12. Primers
FH0211-1 and FH0211-2 contained a NotI site (underlined) and a PstI site
(underlined), respectively. The purified ERG8 PCR product was restricted with
NotI-PstI and subcloned into pGEM-T Easy to create pERG8. The PCR product
containing ERG19 was ligated directly into pGEM-T Easy to create pERG19.
Restriction of pERG8 with NotI-PstI yielded a 1.4-kb DNA fragment containing
ERG8. Restriction of pBRG12 with NotI-PstI was followed by insertion of the
NotI-PstI DNA fragment to create pBRG812 containing both ERG8 and ERG12.
Restriction of pERG19 with AflII-XhoI yielded a 1.2-kb DNA fragment contain-
ing the 39 end of ERG19 missing in pBRG812. Ligation of the 1.2-kb DNA
fragment into the AflII-XhoI sites of pBRG812 gave pFCO1 containing ERG8,
ERG12, and ERG19. Restriction of pFCO1 with XhoI was followed by treatment
with the Klenow fragment and deoxynucleoside triphosphates to create blunt
ends. Subsequent restriction of pFCO1/XhoI/Klenow with SacI yielded a 3.9-kb
DNA fragment containing ERG8, ERG12, and ERG19. The 3.9-kb fragment was
inserted into the SmaI-SacI sites of pNGH1-amp to create pFCO2.
Construction of JM101 dxs::Kanr/pDX4(FH11). An E. coli mutant with a
disruption of the chromosomal dxs gene was constructed as described by Ham-
ilton et al. (14). Competent E. coli JM101 cells were transformed with pDX5 and
grown to an optical density at 600 nm of 0.6 at 30°C. Approximately 10,000 cells
were plated out on LB-chloramphenicol medium prewarmed to 44°C. The plates
were incubated at 44°C, and several of the resulting colonies were picked and
grown at 44°C in 4 ml of LB-chloramphenicol medium. Four 50-ml LB-chlor-
amphenicol cultures were then started with 0.5 ml from four of the 4-ml cultures
and grown overnight at 30°C. Four fresh 50-ml LB-chloramphenicol cultures
were then started with 100 ml of the previous cultures and grown overnight at
30°C. An aliquot of one of the 50-ml cultures was serially diluted 5 3 105-fold,
and 5 ml was plated on LB-chloramphenicol medium. Following incubation at
30°C, the resulting colonies were used to individually inoculate 3 ml of LB-
chloramphenicol/kanamycin medium. Twelve LB-chloramphenicol/kanamycin
cultures were grown overnight at 30°C and used for plasmid DNA isolation. E.
coli cells where the disrupted copy of dxs was incorporated into the genome were
identified by restriction analysis of the isolated plasmid DNA and verified by
sequence analysis of the DNA contained in the plasmids. The strain was desig-
nated FH11.
Construction of FH11/pFMH39, FH11/pFCO2, and FH11/pNGH1-Amp. Col-
onies of E. coli strain FH11 transformed with pFMH39, pFCO2, or pNGH1-
Amp were isolated by incubation at 30°C on LB-kanamycin/ampicillin medium.
Several of the transformants were then grown in LB-kanamycin/ampicillin me-
dium to stationary phase. Restriction analysis of plasmid DNA verified the pres-
ence of pDX4 and pFMH39, pDX4 and pFCO2, or pDX4 and pNGH1-Amp.
Growth of FH11 at 30 and 44°C. Two 50-ml LB-kanamycin samples were
inoculated with 0.5 ml of FH11-(4) and FH11-(7) cultures of cells with the
chromosomal dxs::Kanr knockout. Following growth at 30°C overnight, the cul-
tures were diluted 10,000-fold, and 20-ml portions were spread on LB-kanamycin
plates at room temperature (RT) or prewarmed to 44°C. A sample of FH11 was
also spread on a prewarmed LB-kanamycin plate containing ;7 mg of ME. The
prewarmed plates were incubated overnight at 44°C, and the RT plates were
incubated at 30°C overnight.
Growth of FH11/pFMH3, pFH11/pFCO2, and FH11/pNGH1-Amp at 30 and
44°C. Using the procedure described in the preceding section, FH11/pFMH39,
pFH11/pFCO2, and FH11/pNGH1-Amp were spread on LB-kanamycin/ampi-
cillin plates that were prewarmed to 44°C or kept at RT. Approximately 1.3 mg
of MVA was also spread on the plates used for FH11/pFCO2. The samples were
incubated as described above.
Expression of R. capsulatus dxs and purification of DXPase. Plasmid pFMH30
or pLME10 was used to transform E. coli BL21-DE3-competent cells. LB-
ampicillin cultures (3 ml) were inoculated with single colonies, grown overnight
at 37°C, and used to inoculate 500 ml of M9-CAGM-ampicillin (40). The cultures
were grown at 37°C to an optical density at 600 nm of ;0.6, the temperature was
lowered to 30°C, IPTG was added to a final concentration of 1 mM, and incu-
bation was continued for 5 h. The cells were harvested by centrifugation.
All steps in the purification were done at 4°C. Cell paste (;8 g) from BL21-
DE3/pFMH30 or BL21-DE3/pLME10 was suspended in 40 ml of extraction
buffer consisting of 50 mM sodium phosphate (pH 8), 5 mM b-mercaptoethanol
(BME), 1 mM EDTA, leupeptin (2 mg/ml), pepstatin (1 mg/ml), and 2 mM
phenylmethylsulfonyl fluoride (PMSF) and disrupted by sonication. The result-
ing homogenate was centrifuged at 23,700 3 g to remove cellular debris. (NH4)2
SO4 was added to 46% saturation (26.7 g/100 ml), and the sample was centri-
fuged. The resulting pellet was resuspended in 30 ml of extraction buffer and
centrifuged, and the supernatant was dialyzed against 50 mM sodium phosphate
(pH 8)–10 mM imidazole–150 mM PMSF–5 mM BME to remove the (NH4)2
SO4. A solution of 2 M NaCl was added to the dialyzed supernatant to a final
concentration of 0.5 M. The sample was loaded onto a 1.0- by 10.0-cm Ni-
nitrilotriacetic acid silica column previously equilibrated with 50 mM sodium
phosphate (pH 8)–0.5 M NaCl–10 mM imidazole–5 mM BME (buffer A). The
column was first washed at 1.0 ml/min with 90 ml of 50 mM sodium phosphate
(pH 8)–0.5 M NaCl–30 mM imidazole–5 mM BME (buffer B) and eluted at 1.0
ml/min with a linear gradient of 100% buffer B to 100% buffer C (50 mM sodium
phosphate [pH 8], 0.5 M NaCl, 0.5 M imidazole, 5 mM BME) over 60 ml. Active
fractions were combined and dialyzed against 50 mM Tris-HCl (pH 7.5)–150 mM
PMSF–5 mM BME. The protein was concentrated to 3 to 4 mg/ml by centrifugation
in a Centriprep-30 (Amicon) concentrator and stored in 30% glycerol at 280°C.
Gel filtration of DXPase-A. Size exclusion chromatography was performed on
a 1.6- by 60-cm HiLoad Superdex 200 prep grade gel filtration column (Phar-
macia). All protein samples were kept in 50 mM Tris (pH 7.5) buffer containing
150 mM NaCl, 10 mM MgCl2, and 10 mM BME. The void volume of the column
(40 ml) was measured with Blue Dextran 2000, and the column was calibrated
with BSA (67 kDa), aldolase (158 kDa), and ferritin (440 kDa). The molecular
mass of recombinant R. capsulatus DXPase-A was estimated from a plot of the
logarithm of the molecular mass (log Mr) versus the retention volumes (Kav) of
the eluted proteins by using Grafit (22).
Product analysis. Affinity-purified R. capsulatus DXPase was incubated with
50 ml of 200 mM citrate buffer (pH 6.0) containing 1 mM TPP, 10 mM MgCl2,
50 mM D-glyceraldehyde, and 50 mM pyruvate. After 45 min, a 10-ml portion of
the mixture was loaded onto a silica thin-layer chromatography (TLC) plate and
a second lane was spotted with an authentic sample of 1-deoxy-D-xylulose (DXS)
(3). The plate was developed by published procedures using n-propyl alcohol–
ethyl acetate–H2O (6:1:3) (27). DXP was synthesized from fructose-1,6-diphos-
phate, pyruvate, and TPP with a coupled enzyme system consisting of rabbit
muscle aldolase, TIM, and DXPase-A by the method of Taylor et al. (48). Al-
ternatively, DXP was synthesized from DHAP, pyruvate, and TPP with a coupled
enzyme assay system consisting of TIM and DXPase-B as described below. En-
zymatic and chemically synthesized DXP samples were spotted in adjacent lanes
and analyzed by TLC as described above.
Assays for DXPase. (i) Pyruvate and D-Glyceraldehyde. DXPase activity with
pyruvate and D-glyceraldehyde as substrates was measured by incorporation of
radioactivity into DXS from [2-14C]pyruvate. Pyruvate concentrations were de-
termined using an end-point assay with lactate dehydrogenase and NADH. Assay
mixtures contained 200 mM sodium citrate (pH 7.4), 5 mM dithiothreitol, 2 mM
MgCl2, 2 mM TPP, and various concentrations of [2-14C]pyruvate and D-glycer-
aldehyde in a final volume of 50 ml. The mixtures were preincubated for 5 min
at 37°C, and the reactions were initiated by addition of enzyme. After incubation
at 37°C for 10 min, the reactions were quenched by the addition of either 50 ml
of 0.5 M EDTA or 325 ml of 1:1 (vol/vol) methanol-CHCl3. The reaction mix-
tures were clarified by centrifugation, and 50 or 125 ml was loaded onto a 0.5- by
7.0-cm silica gel grade 60, 200- to 400-mesh column containing 1.0 cm of Na2SO4.
[2-14C]DXS was eluted with 11 to 12 ml of 1:3 (vol/vol) methanol-CHCl3. The
solvent was removed with a gentle stream of nitrogen, the residue was resuspended
in 1 ml of methanol, and the mixture was vortexed for 20 s. ULTIMA GOLD
scintillation fluid (10 ml) was added, the solutions were vortexed for 30 s, and
radioactivity was measured by liquid scintillation spectrometry.
(ii) Pyruvate and GAP. Assay mixtures contained 200 mM sodium citrate (pH
7.4), 10 mM MgCl2, 2 mM TPP, 0.025 to 25 mM [2-14C]pyruvate (0.10 to 7.9
mCi/mmol), and 1.0 to 40 mM DHAP. TIM (15 U) was added, and the tubes were
equilibrated at RT for 45 min. The assay was initiated by the addition of affinity-
purified DXPase to a final volume of 50 ml. Incubations were carried out at 37°C
for 2 to 13 min. The reaction was quenched by heating at 80°C for 2 min. The
samples were cooled at 0°C for 5 min, the MgCl2 concentration was adjusted to
50 mM, and 10 U of SAP was added. The reaction mixture was incubated at 37°C
for 90 min and clarified by centrifugation. A 25-ml portion was loaded onto a
silica column as described above for DXS. The radioactivity in [2-14C]DXS was
measured as described above. Initial velocities were determined from the slope
of a plot of product versus time.
Steady-state kinetic constants for DXPase. Steady-state kinetic constants de-
termined for pyruvate and D-glyceraldehyde were measured at saturating con-
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centrations of the second substrate, 2.5 to 100 mM D-glyceraldehyde, and 0.25 to
25 mM [2-14C]pyruvate (0.10 mCi/mmol). Reactions were run at 37°C in buffer
containing 200 mM sodium citrate (pH 7.4), 2 mM MgCl2, 2 mM TPP, and
affinity-purified DXPase (6.0 to 7.5 mg) and were quenched by the addition of
EDTA to a final concentration of 250 mM. Conversion of the limiting substrate
was 10% or less. The Km and Vmax of D-glyceraldehyde and pyruvate were
obtained by fitting the data to the Michaelis-Menten equation using Grafit (22).
Steady-state kinetic constants determined for pyruvate and GAP were mea-
sured at saturating concentrations of the second substrate. Reactions were run at
37°C in mixtures containing 200 mM sodium citrate (pH 7.4), 10 mM MgCl2, 2
mM TPP, 0.025 to 15 mM [2-14C]pyruvate (0.10 to 7.9 mCi/mmol), 0.25 to 35 mM
DHAP (0.04 to 1.4 mM GAP), 15 U of TIM, and affinity-purified DXPase (1 to
3 mg). The reactions were quenched by heating at 80°C for 2 min, and the
products were treated with SAP as described above. Initial velocities were de-
termined from the slope of a plot of product versus time. Km and Vmax for GAP
and pyruvate were obtained by fitting the data to the Michaelis-Menten equation
using Grafit (22).
Metal ion dependence. DXPase-A activity was measured in 200 mM sodium
citrate (pH 7.4)–2 mM TPP–50 mM [2-14C]pyruvate (0.084 mCi/mmol)–50 mM
D-glyceraldehyde–0.01 to 20 mM Mg21, Mn21, or Ca21 in a total volume of 50
ml. The assay mixtures were preincubated at 37°C for 5 min, the reactions were
initiated by the addition of 7.5 mg of DXPase-A, and the mixtures were incubated
at 37°C for 10 min. The reactions were quenched by the addition of 325 ml of 1:1
(vol/vol) methanol-CHCl3, and the radioactivity in [2-14C]DXS was measured as
described above.
Inhibition by DHAP. Assay mixtures containing 200 mM sodium citrate (pH
7.4), 2 mM MgCl2, 2 mM TPP, 20 mM [2-14C]pyruvate (0.034 mCi/mmol), 25 mM
D-glyceraldehyde, and 0 to 80 mM DHAP were preincubated at 37°C for 5 min.
The reaction was initiated by the addition of 6 mg of DXPase-A. The assay
mixtures were incubated at 37°C for 10 min before the addition of EDTA to a
final concentration of 250 mM. The radioactivity in [2-14C]DXS was measured as
described above.
RESULTS
R. capsulatus ORF 2816 carries dxsA, the gene for DXPase-A.
Database searches were conducted using the entire translated
sequence of ORF 2816, corresponding to nucleotides 43929 to
45854 (previously designated ORF 641 [GenBank accession
no. Z11165]) in the photosynthesis gene cluster of R. capsu-
latus. The initial results revealed a strong similarity to both
transketolases and the E1 component of pyruvate dehydroge-
nases involved in pyruvate decarboxylation. These motifs were
consistent for an enzyme that catalyzes the synthesis of DXP
by condensation of GAP the two-carbon acetyl acyl anion pro-
duced by a thiamine-mediated decarboxylation of pyruvate.
This mechanism, initially proposed by Rohmer et al. (38), is
similar to those for reactions catalyzed by transketolases. Sev-
eral hypothetical proteins were also found with substantial
similarity to the protein encoded by ORF 2816, including gene
products from Arabidopsis thaliana CLA1 (accession no.
U2709), Synechocystis sp. hypothetical protein PID:d1017822
(accession no. D90903), Haemophilus influenzae hypothetical
FIG. 2. Pairwise alignment of R. capsulatus DXPase-A and DXPase-B. Regions of homology are shown by a shaded background. The 402
identical residues are indicated by asterisks, the thiamine diphosphate binding motif is in bold, and the DRAG signature sequence is in bold italics.
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protein HI1439 (Swiss-Prot accession no. P45205), Escherichia
coli hypothetical protein PID:g1773104 (accession no. U82664),
Bacillus subtilis hypothetical protein (Swiss-Prot accession no.
P54523), and Mycobacterium tuberculosis hypothetical protein
(Swiss-Prot accession no. O07184). Shortly after our search
was conducted, two other groups reported that the hypothet-
ical E. coli protein was a DXPase (27, 46). Their results pro-
vided strong evidence that R. capsulatus ORF 2816 encoded
DXPase-A. We discovered several proteins labeled as trans-
ketolases, for example, Mycobacterium leprae (accession no.
U15181) and Streptomyces coelicolor (accession no. AL049485),
that appear to be DXPases based on the presence of a highly
conserved “DRAG” sequence (see below). Other putative
DXPases identified in subsequent searches included a second
M. tuberculosis protein (accession no. AL009198), the 626-
amino-acid translation product of Neisseria gonorrhoeae (Con-
tig320, an unfinished fragment of the genome deposited at
NCBI), and a protein from the unicellular eukaryote Plasmo-
dium falciparum (accession no. AF111814).
R. capsulatus ORF 2895 carries dxsB, a second gene for
DXPase. A BLAST search at the University of Chicago R. cap-
sulatus website (see above) using E. coli dxs as the query se-
quence uncovered a second ORF in R. capsulatus, which we sub-
sequently identified as DXPase-B biochemically. DXPase-B is
a 636-amino-acid protein, compared to DXPase-A with 641
amino acids. DXPase-A and DXPase-B have 64.3% identity
over a sequence of 622 residues (Fig. 2).
Sequence comparisons. DXPases vary in length from 536
amino acids in M. tuberculosis to 739 residues in A. thaliana.
However, most of the proteins are similar in length to the two
Rhodobacter proteins. A multiple sequence alignment was con-
ducted using DXPase-A from R. capsulatus and 10 of the
proteins described above to identify conserved amino acids and
regions of significance. A total of 93 residues in the set were
invariant. A highly conserved region with a high level of sim-
ilarity to the consensus TPP binding motif (15, 34) corresponds
to residues 151 to 181 in the Rhodobacter DXPase-A protein
and residues 150 to 180 in the DXPase-B protein (Fig. 2).
DXPase-A also has a substantial degree of similarity to
transketolases. Identical residues are distributed throughout
the entire sequences of transketolases and the Rhodobacter
DXPases. Many residues known to be important for binding
and/or catalysis in transketolases are also present in the Rho-
dobacter proteins. Table 2 correlates key amino acids in yeast
transketolase, along with their roles assigned in catalysis, with
their counterparts in Rhodobacter DXPase-A and DXPase-B.
Schenk et al. (41) have designated a highly conserved region
consisting of 36 amino acids important for structure and func-
tion in transketolases as a “transketolase motif.” An analo-
gous region was found for residues 419 to 454 in Rhodobac-
ter DXPase-A. A cluster of four residues, THDS, located at the
beginning of the transketolase motif is replaced by a DRAG
cluster in all of the sequences unambiguously shown to be
DXPases. The product of a putative dxs gene in Plasmodium
falciparum has a four-residue GRSG sequence instead of the
DRAG motif; however, the protein also lacks the His residue
of THDS conserved in all transketolases. We identified addi-
tional putative dxs genes in NCBI databases using the Rhodo-
bacter DXPase-A sequence as a probe. These include ORFs
from Neisseria meningitidis, Pseudomonas aeruginosa, and De-
inococcus radiodurans. A key element to our identification of
putative DXPases is the DRAG signature sequence (Fig. 2),
which has been identified in a wide variety of organisms, in-
cluding Synechocystis sp., Bacillus subtilis, Rhodobacter capsu-
latus, Arabidopsis thaliana, Oryza sativa, Mentha 3 piperita,
Escherichia coli, Haemophilus influenzae, Pseudomonas aerugi-
nosa, Neisseria meningitidis, Neisseria gonorrhoeae, Porphy-
romonas gingivalis, Helicobacter pylori, Campylobacter jejuni,
Aquifex aeolicus, Clostridium acetobutylicum, Deinococcus ra-
diodurans, Treponema pallidum, Mycobacterium leprae, Myco-
bacterium tuberculosis, Streptomyces coelicolor, Mycobacterium
tuberculosis, Chlamydia trachomatis, and Plasmodium falciparum.
A multiple sequence alignment of the Rhodobacter DXPase-A
sequence with several pyruvate dehydrogenase E1 component
sequences was also performed. The most striking feature of
the alignment was the homology of the N-terminal part of
DXPase-A to the l subunit of the E1 component and the
homology of the C-terminal end of the Rhodobacter sequence
to the b subunit of the E1 component.
R. capsulatus ORF 2895 complements E. coli dxs::Kanr. Fol-
lowing the construction of strain FH11, the episomal copy of
dxs contained in pDX4 was turned off at 44°C. The inability of
FH11 to grow at the restrictive temperature demonstrates that
dxs is an essential single-copy gene in E. coli. The strain was
TABLE 2. Comparison of conserved transketolase residues with those in DXPase-A and DXPase-Ba
DXPase-A
residue
DXPase-B
residue
Transketolase
residue Function Reference(s)
H80 H79 H69 Stabilization of reaction intermediate; binds C-1 hydroxyl of donor substrate 53
H49 H48 H30 Acid-base catalyst (proton acceptor or donor) 53
H258 H257 H263 Acid-base catalyst (proton acceptor or donor) 53
D152 D151 D157 Metal binding (side chain) 42
N181 N180 N187 Metal binding (side chain) 42
M183 M182 I189 Metal binding (main-chain oxygen) 42
D429 D428 D477 Binds C-2 hydroxyl of acceptor substrate; enantioselectivity of enzyme 30, 42
H433 H432 H481 Transition-state stabilization 53
E372 E372 E418 Binds N-19 nitrogen of TPP cofactor (essential for catalytic activity) 42, 52
R480 R479 R528 Phosphate binding of substrate 31, 42
Y394 Y393 F442 Interaction with pyrimidine ring of TPP 42
F397 F396 F445 Interaction with pyrimidine ring of TPP 42
Y402 Y401 Y448 Interaction with pyrimidine ring of TPP 42
a Important conserved residues from S. cerevisiae transketolase and the similarly conserved residues in R. capsulatus DXPase-A and DXPase-B are compared. The
proposed function of these residues is based on numerous studies of transketolases reported in the literature.
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rescued at 44°C by addition of ME, an advanced intermediate
in the pathway, to the medium (8). To establish that ORF 2895
encodes a functional DXPase, FH11 cells were transformed
with pFMH39. FH11/pFMH39 cells were able to grow at the
restrictive temperature of 44°C, whereas FH11/pNGH1-Amp
cells, containing the expression vector without the dxs insert,
did not grow. The results are illustrated in Fig. 3 for ORF 2895.
The ability of R. capsulatus ORF 2895 to complement E. coli
dxs::Kanr provides genetic evidence that it encodes DXPase-B.
Synthesis of IPP from MVA in E. coli. The three yeast genes
ERG8, ERG12, and ERG19 were isolated by PCR and were
translationally coupled with overlapping start and stop codons
(29) in the synthetic operon contained within pFCO1. The
PCR primers for all three yeast genes contained additional
nucleotides for the ribosome binding site AGGAGGAG and
the insertion of Gln-Glu-Glu-Phe at the C terminus of the
encoded proteins to facilitate their purification using a mono-
clonal antibody column (29). The gene for MVA kinase,
ERG12, served as the foundation for the construction of the
operon. ERG8, the gene for phospho-MVA kinase, was added
upstream of ERG12, and ERG19, the gene for MVA diphos-
phate decarboxylase, was appended to the 39 end of ERG12.
To ensure specific annealing to ERG12, the additional nucle-
otides corresponding to codons for the N terminus of MVA
diphosphate decarboxylase were altered during the design of
primer FH0129 to direct the synthesis of the correct amino
acids using codons as different as possible from wild-type
ERG19. A cassette containing the coupled yeast genes was
TABLE 3. Summary of purification of R. capsulatus DXPase-A
Step
Amt of
protein
(mg)
Sp acta
(mmol/min/
mg)
Total
activity
(mmol/min)
Purifi-
cation
(fold)
Recovery
(%)
Supernatant 493 0.18 89 1 100
40% (NH4)2SO4
precipitate
213 0.35 75 2 84
Ni21-silica affinity
column
25 1.6 40 10 45
a DXPase-A activity was determined with 25 mM [2-14C]pyruvate (0.06 mCi/
mmol), 100 mM D-glyceraldehyde, and 2 mM MgCl2. Reactions were quenched
by the addition of EDTA to a final concentration of 250 mM as described in
Materials and Methods.
FIG. 3. Growth of E. coli FH11 at 30 and 44°C. FH11 cells with chromosomal dxs::Kanr and episomal dxs under the control of the
temperature-sensitive origin of replication contained in pMAK705 (14) were grown under the following conditions. (A) FH11 cells were able to
grow at 30°C on LB-kanamycin medium. (B) FH11 cells were unable to grow at the nonpermissive temperature of 44°C on LB-kanamycin medium,
establishing that E. coli dxs is an essential gene. (C) FH11 cells with R. capsulatus ORF 2895 contained in pFMH39 were able to grow at the
nonpermissive temperature of 44°C on LB-kanamycin/ampicillin medium, establishing that R. capsulatus ORF 2895 carries dxsB. (D) FH11/
pNGH1-Amp cells containing the parent vector of pFMH39 and pFCO2 were unable to grow at 44°C on LB-kanamycin/ampicillin medium. (E)
FH11/pFCO2 cells were able to grow at 44°C on LB-kanamycin/ampicillin medium supplemented with 50 mg of mevalonic acid per ml, establishing
the ability of the synthetic operon contained within pFCO2 to synthesize IPP. (F) FH11 cells were able to grow at the nonpermissive temperature
of 44°C on LB-kanamycin medium containing ;0.3 mg of ME per ml.
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removed from pFCO1 and inserted into pNGH1-Amp to give
pFCO2 in order to test the ability of the operon to complement
the dxs::Kanr disruption in FH11 grown on MVA. FH11/
pFCO2 transformants did not grow at the restrictive temper-
ature of 44°C unless MVA (50 mg/liter) was added to the growth
medium (Fig. 3), thus establishing the ability of the synthetic
operon to direct the synthesis of IPP from MVA in E. coli.
Expression and purification of DXPase. E. coli strains BL21-
DE3/pFMH30 and BL21-DE3/pLME10 produce recombinant
R. capsulatus DXPase-A and DXPase-B, respectively, to
approximately 5 and 3% of total cellular protein. Both en-
zymes were purified to .95% homogeneity in two steps by
(NH4)2SO4 precipitation followed by Ni
21-silica affinity chro-
matography (results for DXPase-A are given in Table 3). The
purified enzymes were isolated in 45% (DXPase-A) and 30%
(DXPase-B) yields and stored at 220°C in dialysis buffer (50
mM Tris-HCl [pH 7.5], 5 mM BME, 150 mm PMSF) contain-
ing 30% glycerol until needed, with no significant decrease in
enzyme activity for 4 to 6 weeks. An SDS-PAGE gel of samples
from each purification step of DXPase-A is shown (Fig. 4).
After Ni21-silica affinity chromatography, SDS-PAGE of the
sample gave a single band at 68 kDa, as expected for the
protein encoded by dxsA (Fig. 4). Similar results were obtained
for dxsB (data not shown).
Product analysis. The identity of the product from pyruvate
and D-glyceraldehyde was confirmed by a comparison of TLC
mobility with an authentic sample of DXS. An attempt to use
a commercial sample of GAP to establish the structure of DXP
in a parallel experiment was unsuccessful. We then used the
method of Taylor et al. (48) to synthesize GAP from fructose-
1,6-diphosphate with rabbit muscle aldolase. The aldolase
products, GAP and DHAP, were isomerized with TIM to gen-
erate a constant supply of GAP for DXPase. Alternatively,
GAP was generated in situ from commercially available DHAP
and TIM. The Rf of the DXPase product upon TLC was iden-
tical to that of authentic DXP.
R. capsulatus DXPase-A is a homodimer. The molecular
mass of affinity purified recombinant DXPase-A was estimated
by gel filtration chromatography (Fig. 5). The molecular mass
was determined to be 141 kDa, consistent with a homodimer of
68-kDa subunits calculated from the gene sequence.
Biochemical properties of recombinant DXPase-A. Maximal
activity for R. capsulatus DXPase-A required the addition of
a divalent metal, either Mn21 or Mg21 (Fig. 6). DXPase-A
showed optimal activity at concentrations between 0.05 and
1 mM for Mn21 and between 2 and 10 mM for Mg21. Only 30
to 40% of the maximal activity was achieved with Ca21 over a
range of concentrations between 0.01 and 20 mM. A require-
ment for a divalent metal by DXPase-A is consistent with that
by other TPP-dependent enzymes. Pyruvate decarboxylases,
transketolases, benzoylformate decarboxylases, pyruvate oxi-
FIG. 4. Purification of R. capsulatus DXPase-A. Samples from each
purification step were electrophoresed on a 0.1% SDS–12% polyacryl-
amide gel and stained with Coomassie blue. Lanes: 1 and 6, molecular
mass standards (at 20, 30, 40, 50, 70, and 100 kDa); 2, cell extract of
BL21/pFMH30 without IPTG induction (;40 mg); 3, cell extract of
BL21/pFMH30 with IPTG induction (;70 mg); 4, ammonium sulfate
precipitation (;50 mg); 5, Ni21-silica affinity chromatography (;9 mg).
FIG. 5. Determination of the molecular mass of R. capsulatus
DXPase-A by gel filtration chromatography. The retention volume of ;2
mg of purified recombinant R. capsulatus DXPase-A was measured on
a calibrated HiLoad Superdex 200 prep grade gel filtration column
(Pharmacia) with BSA (Mr 5 67,000), aldolase (Mr 5 158,000), and
ferritin (Mr 5 440,000) as standards. Using the formula Kav 5 (column
void volume 2 elution volume)/(column bed volume 2 column void
volume), Kav
DXPase-A 5 0.313 and Mr 5 141,000. Since Mr 5 67,940 for
the protein encoded by dxsA, the enzyme is most probably a ho-
modimer.
FIG. 6. Metal requirements for DXPase-A were determined under
standard assay conditions with 50 mM [2-14C]pyruvate (0.08 mCi/
mmol), 50 mM D-glyceraldehyde, 7 mg DXPase-A, and different con-
centrations of either Mn21 (F), Mg21 (E), or Ca21 (■). Reactions
were quenched by the addition of methanol-CHCl3 (1:1) as described
in Materials and Methods.
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dases, and acetolactate synthases all catalyze TPP-dependent
reactions in the presence of Mg21 (43).
Michaelis constants for pyruvate and GAP were determined
by a coupled assay where GAP was generated in situ from
DHAP by TIM. The DHAP/GAP equilibrium is displaced
toward DHAP, and GAP concentrations were based on the
96:4 equilibrium ratio for DHAP to GAP reported for TIM
(50). Thus, 50 mM DHAP gave 2 mM GAP in the coupled
assay system when the activity of TIM was in substantial excess
over DXPase. Due to the unfavorable ratio and the large
amount of DHAP with respect to GAP, it was necessary to
establish that DHAP does not inhibit DXPase. When DXPase
was incubated with 25 mM pyruvate, 25 mM D-glyceraldehyde,
and 0 to 80 mM DHAP, no decrease in DXPase activity due to
inhibition by DHAP was seen (data not shown).
Michaelis constants for pyruvate and GAP were determined
by fitting hyperbolic plots of initial velocities versus substrate
concentration (Fig. 7) from initial velocities calculated from
the slope of product (DXS) versus time plots at each concen-
tration of varied substrate. DXPase-A gave Km
pyruvate 5 610 6
50 mM, Km
GAP 5 150 6 10 mM, and Vmax 5 1.9 6 0.1 mmol/
min/mg, while DXPase-B gave Km
pyruvate 5 3.0 6 0.2 mM,
Km
GAP 5 120 6 14 mM, and Vmax 5 1.4 6 0.1 mmol/min/mg.
When GAP was replaced by D-glyceraldehyde, DXPase-A gave
Km
pyruvate 5 4.3 6 0.2 mM, Km
D-glyceraldehyde 5 14 6 2 mM,
and Vmax 5 1.6 6 0.1 mmol/min/mg and DXPase-B gave
Km
pyruvate 5 14 6 1 mM, Km
D-glyceraldehyde 5 10 6 2 mM, and
Vmax 5 1.0 6 0.1 mmol/min/mg. The aldehyde substrates D-
glyceraldehyde and GAP exist primarily as aldehyde hydrates
in solution, unlike pyruvate. For D-glyceraldehyde, the effective
aldehyde concentration is only 4.4% of the total substrate
concentration (2); thus, the Km values for the aldehyde sub-
strates are considerably lower than Km
pyruvate. The Vmax values
we measured for the R. capsulatus enzymes are similar to
previously reported activities for DXPases from other organ-
isms (21, 27, 46), except for E. coli, where Vmax 5 300 to 370
mmol/min/mg and Km
pyruvate 5 65 to 96 mM (18). The optimal
pH for R. capsulatus DXPase-A in sodium citrate buffer was
7.0 to 7.5. The enzyme was noticeably less active at pH 7.5 in
several other buffers (HEPES, morpholinepropanesulfonic
acid [MOPS], and bicyclo[2.2.1]hept-5-en-2,3-dicarboxylic acid
[BHDA]) that we examined. To ensure that the sodium citrate
buffer was not inhibiting the enzyme, glycylglycine, a buffer
commonly utilized in transketolase assays (45), was also inves-
tigated. For buffer concentrations of sodium citrate and glycyl-
glycine between 50 and 200 mM, the activity of DXPase
changed by less than 20%. Km
pyruvate was unaltered in sodium
citrate and glycylglycine buffers.
DISCUSSION
Bacteria typically require isoprenoid compounds for synthe-
sis of respiratory quinones, synthesis of cell walls, and modifi-
cation of tRNAs. Photosynthetic bacteria also require chloro-
phyll for light harvesting and carotenoids for protection against
UV radiation (1). Related photosynthesis compounds are pro-
duced in plant plastids, along with a wide variety of other
monoterpenes (11) and diterpenes (9). Bacterial isoprenoids
are synthesized by the MEP pathway in the species examined
to date, except for a strain of Streptomyces (44), which has both
the MEP and MVA pathways. Both pathways are also found in
plants, where isoprenoid compounds synthesized in the cytosol
are derived from MVA and those produced in plastids are
derived from MEP (25, 26). The MEP and MVA pathways
converge at IPP, and the reactions in the isoprenoid pathway
are similar beyond that point in all organisms.
DXP is a key intermediate in bacterial metabolism. The
deoxy sugar is the substrate for the first pathway-specific en-
zyme in the biosynthesis of thiamine, pyridoxol, and isopre-
noids (38). Searches of the E. coli genome have provided no
evidence for genes in the MVA pathway, and those in the MEP
pathway that have been identified thus far appear to occur as
single copies. We constructed a dxs knockout in E. coli that was
complemented by wild-type dxs on a temperature-sensitive
plasmid. The strain was not viable at the restrictive tempera-
ture but was rescued when grown on media supplemented with
B vitamins and ME, thus confirming that dxs is an essential
single-copy gene for the biosynthesis of isoprenoid compounds.
Moreover, when cotransformed with a plasmid carrying the
yeast genes necessary to convert MVA to IPP, the knockout
FIG. 7. Substrate saturation curves for DXPase-A determined in
the presence of a fixed concentration of the second substrate utilizing
a coupled enzyme assay. GAP is generated in situ by utilizing a coupled
enzyme assay starting with dihydroxyacetone phosphate. (A) Different
concentrations of GAP (0.03 to 1.0 mM) and 5 mM [2-14C]pyruvate
(0.10 to 7.9 mCi/mmol). (B) Different concentrations of [2-14C]pyruvate
(0.025 to 15 mM) and 1.2 mM GAP. The assay mixtures contained 2
mM MgCl2, 15 U of TIM, and 3 mg of DXPase-A, and the reactions
were quenched by heating at 80°C and treated with SAP as described
in Materials and Methods. The initial velocities were determined from
the slope of a plot of time versus product for each concentration of
GAP and pyruvate (data not shown).
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strain was viable at the restrictive temperature when grown on
MVA. While this experiment demonstrates that there is no
special requirement for the MEP pathway in E. coli beyond
synthesis of IPP, isoprenoid metabolism in E. coli appears to be
more complex. In the MVA pathway, IPP is produced by
fragmentation of phosphorylated MVA, and the subsequent
isomerization of IPP to DMAPP is mandatory. However, when
Hahn et al. disabled idi, the gene encoding IPP isomerase in
E. coli, the resulting strain was viable (12). A careful search of
E. coli databases using several different probe sequences did
not retrieve any additional E. coli idi genes. These results are
most easily explained if one assumes that the MEP pathway in
E. coli produces both IPP and DMAPP and that IPP isomerase
performs the nonessential role of balancing the pool of the two
metabolites as they are converted to respiratory quinones and
dolichols. Recent labeling studies for E. coli with intact cells
(7) and with purified enzymes (23, 24) are consistent with this
hypothesis.
R. capsulatus encodes all of the enzymes needed to synthe-
size photosynthetic isoprenoids from IPP in a 46-kb cluster. As
observed for E. coli, disruption of the copy of idi located in the
photosynthesis cluster of R. capsulatus is not lethal (4). A
Southern analysis of R. capsulatus genomic DNA has provided
evidence for a second gene for IPP isomerase (13). In addition,
a more recent search of newly deposited DNA sequences using
idi in the photosynthesis gene cluster as a probe revealed a
second gene carried by ORF 735, which is located at a site
remote from the cluster. Thus, the photosynthetic bacterium
appears to have two genes that encode IPP isomerase, idiA in
the photosynthesis cluster and idiB located elsewhere in the
chromosome (13). We do not know if, like E. coli, R. capsulatus
can survive without a functional copy of idi.
We initially identified the ORF for DXPase-A in the
R. capsulatus photosynthesis cluster from the substantial sim-
ilarity between regions in the encoded protein and those in
pyruvate decarboxylases and transketolases, enzymes that cat-
alyze similar reactions needed for synthesis of DXP from pyru-
vate and GAP. An ORF (ORF 2895) for a second synthase,
DXPase-B, was subsequently identified from R. capsulatus af-
ter additional sequences had been placed in the database.
Interestingly, the genes encoding the enzymes in the MEP
pathway between DXPase and IPP isomerase that have been
thus far characterized do not appear to be located in the pho-
tosynthesis cluster. For example, the putative gene for DXP
reductoisomerase, the next enzyme in the pathway, is found on
the 690-kb contig 1A01-1C09 located elsewhere in the chro-
mosome. Like the second idi gene, the gene for DXPase-B is
not in the photosynthesis cluster.
The DXPases represent a new class of TPP-dependent en-
zymes whose chemical properties combine traits of pyruvate
decarboxylases and transketolases. They first catalyze a TPP-
dependent decarboxylation of pyruvate, by analogy to pyruvate
decarboxylases. The enzyme-bound thiamine-stabilized acetyl
anion is then transferred to the aldehyde moiety in GAP in a
reaction similar to the related transfer of the glycolyl anion by
transketolases. A comparison of amino acid sequences reveals
conserved elements of both pyruvate decarboxylases and tran-
sketolases in DXPases. Multiple sequence alignments show
significant homology in the N-terminal region of R. capsulatus
DXPases to a region in the g subunit of the E1 component of
pyruvate dehydrogenases and homology between sequences
from the C-terminal region of DXPase with a region in the b
subunit of the dehydrogenases (15). The homology to transke-
tolases is even more substantial. Identical residues are distrib-
uted throughout the entire polypeptide chains of DXPase-A,
DXPase-B, and transketolases, including many specifically
identified as being important for binding and catalysis in tran-
sketolases (42). In particular, a 36-amino-acid sequence in the
DXPases, beginning with I420 in DXPase-A, aligns with the
highly conserved “transketolase motif” identified by Schenk et
al. (41). However the conserved THDS four-residue block at
the beginning of the 36-amino-acid motif in transketolases is
replaced by a DRAG sequence in DXPases. The only excep-
tion to the DRAG signature found to date is a closely related
GRSG block seen in the putative DXPase from Plasmodium
falciparum.
The biochemical properties of the R. capsulatus DXPases
are similar to those reported for the E. coli (27, 46) and Men-
tha 3 piperita (21) proteins. Although pyruvate and GAP are
preferred substrates, the enzymes synthesize 1-deoxy-D-xylu-
lose when incubated with pyruvate and D-glyceraldehyde. The
major difference in the catalytic efficiencies of the two reac-
tions results from a Km for glyceraldehyde that is approxi-
mately 100-fold higher than the Km for GAP. Similar activity
has been reported for sugars involved in transketolization re-
actions (49). DXPase-A appears to be a homodimer. Given the
substantial degree of similarity among DXPases, we anticipate
that the other enzymes are homodimers as well.
In summary, isoprenoid compounds are synthesized from
1-deoxy-D-xylulose 5-phosphate in plant chloroplasts and most
bacteria by the MEP pathway. In E. coli, DXPase is encoded by
dxs, an essential single-copy gene. A disruption in dxs can be
complemented chemically by ME, which is presumably phos-
phorylated and then processed normally by the MEP pathway.
The disruption can also be complemented by mevalonate when
the yeast genes required to convert MVA to IPP are present
on a plasmid. In contrast to E. coli, R. capsulatus has two dxs
genes. dxsA is located in the photosynthesis cluster, along with
all of the other genes required to synthesize isoprenoid com-
pounds necessary for photosynthesis, while dxsB is located else-
where in the chromosome. A similar redundancy was found in
R. capsulatus for idi, the gene encoding IPP isomerase. Inter-
estingly the genes encoding other enzymes in the MEP path-
way are apparently not located in the photosynthesis cluster.
The occurrence of two genes for DXPase and for IPP isomer-
ase, one in the photosynthesis cluster and one elsewhere, raise
interesting questions about regulation of the biosynthesis of
isoprenoids during aerobic and photosynthetic anaerobic growth.
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